Over at In the Pipeline, Derek Lowe blogs about the outcome of all those compounds that are discovered but can't be used as therapeutics. After looking at a particular compound that will never be used as a therapeutic, he writes, "But all this brings up another thing that we were talking about around here -- how much do drug companies owe academia for working out fundamental biochemistry and molecular biology?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more